Cargando…
A pharmacokinetic basis for improving therapeutic outcomes of aminoglycoside therapy during continuous venovenous haemodiafiltration
Autores principales: | Spooner, A, Corrigan, O, Donnelly, M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4095155/ http://dx.doi.org/10.1186/cc5261 |
Ejemplares similares
-
Elimination of linezolid in patients undergoing low-flow continuous venovenous haemodiafiltration
por: Ide, T, et al.
Publicado: (2012) -
An open prospective study of amikacin pharmacokinetics in critically ill patients during treatment with continuous venovenous haemodiafiltration
por: D’Arcy, Deirdre M, et al.
Publicado: (2012) -
Citrate anticoagulation for continuous venovenous haemodiafiltration: the impact of a novel protocol on patients receiving therapy in one regional hospital
por: Highgate, J, et al.
Publicado: (2015) -
Valproic acid overdose and continuous venovenous haemodiafiltration
por: Jacobs, Frédéric M., et al.
Publicado: (2008) -
Exploring population pharmacokinetic models in patients treated with vancomycin during continuous venovenous haemodiafiltration (CVVHDF)
por: Kirwan, Marcus, et al.
Publicado: (2021)